癌症诊断知情患者首次化疗期间情绪障碍的评估与探讨

Evaluation of the mood obstacle of the diagnosis informed cancer patients during the first chemotherapy

目的研究和探讨癌症诊断知情患者首次化疗期间的情绪状态、变化原因及应对干预措施。方法采用焦虑自评量表（SAS）和抑郁自评量表（SDS）对112例癌症诊断知情患者进行评测。结果112例癌症诊断知情患者中抑郁程度指数〉0．5者最高时达104例，占被调查者的92．86％。化疗前1周、化疗前夜、化疗中和化疗后1周抑郁分别为88．39％、92．86％、87．50％、79．46％，以轻度抑郁为主。焦虑情绪评分在化疗前夜达到高峰。结论应该重视恶性肿瘤患者首次化疗期的情绪变化，避免焦虑和中、重度抑郁的出现，有利于患者首次化疗过程的顺利进行及后续化疗的继续实施，以利患者的顺利康复，提高生活质量，并减少患者轻生意念甚至因此而导致的更为严重的后果。

Objective To study and explore the mood states, reasons for change and interven- tions of the diagnosis informed cancer patients during their first chemotherapy. Methods Use self- rat- ing anxiety scale （SAS） and self- rating depression scale （SDS） to estimate and test the 112 patients. Results There were 104 patients whose depression degree index was more than 0.5 in the most serious, that was 92.86%. The index were separately 88.39%, 92.86%, 87.50%, 79.46% one week before, the night before, among and one week after the first chemotherapy. There were mainly in light depression, and the anxiety moods reach the peak was the night before. Conclusions Attention should be paid for the emotional changes in patients with malignant tumors during the first chemotherapy, avoiding anxiety, medium and heavy depression in order to success in their first chemotherapy and subsequent chemotherapy continued, good for their recovery, improving the quality of their lives and reduce patients to commit suicide ideas and even more serious consequences.